Biosimilars
are subsequent products or generics of biopharmaceuticals. First single-use production facilities for biosimilars, such as the ones from Alvotech in Iceland, are currently under construction.
are subsequent products or generics of biopharmaceuticals. First single-use production facilities for biosimilars, such as the ones from Alvotech in Iceland, are currently under construction.